BFJPM ameliorates OVA-induced food allergy in a murine model accompanied by gut microbiota remodeling
-
By
-
Xue Yang
-
Huiyi Peng
-
Rao Hu
-
Yifan Li
-
Ping Jiang
-
May 28, 2026
-
Clinical Scorecard: BFJPM Reduces OVA-Induced Food Allergy Symptoms in Mice and Alters Gut Microbiota Composition
At a Glance
| Category | Detail |
| Condition | |
| Key Mechanisms | |
| Target Population | Pediatric population with food allergies (children) |
| Care Setting | |
Key Highlights
- Saccharopolyspora may have clinical implications for food allergy management.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- Monitor gut microbiota changes alongside serum total IgE levels and allergy symptom scores.
Risks
Patient & Prescribing Data
BFJPM may offer a new approach for managing food allergies by modulating gut microbiota and immune response.
Clinical Best Practices
- Consider integrating BFJPM with existing therapies for a comprehensive management approach.
Related Resources & Content